Noninvasive Molecular Markers in Gynecologic Cancers

In cancer treatment, non-invasive diagnosis can avoid complications of biopsy and other unfavorable impacts on patient's health. DNA, methylation, SNPs, miRNA, mRNA, protein, autoantibodies, metabolite, and Omics-based markers from remote media such as blood, plasma, and urine are emerging as noninvasive molecular markers with high specificity and sensitivity towards many cancers. In many instances, these markers are also emerging as next-generation personalized diagnostics and targets or therapeutics for personalized cancer treatment. This book classifies the available molecular tumor markers according to their principal characteristics and relative methodologies.

Info autore

Debmalya Barh, Mehmet Gunduz

Dettagli sul prodotto

• Autori: Debmalya Gunduz Barh
• Con la collaborazione di: Debmalya Barh (Editore), Mehmet Gunduz (Editore), Barh Debmalya (Editore), Gunduz Mehmet (Editore)
• Editore: Taylor & Francis Ltd.
• Contenuto: Libro
• Forma del prodotto: Tascabile
• Data pubblicazione: 29.01.2024
• Categoria: Scienze naturali, medicina, informatica, tecnica > Biologia
• EAN: 9781138749504
• ISBN: 978-1-138-74950-4
• Numero di pagine: 516
• Categorie: MEDICAL / Clinical Medicine, Breast Cancer, MEDICAL / Pharmacology, MEDICAL / Biotechnology, TECHNOLOGY & ENGINEERING / Biomedical, Biology, life sciences, CC, EC, ESS, CERVICAL CANCER, ovarian cancer, DNA Methylation, endometrial cancer, Uterine sarcoma, CTCs, Vaginal cancer, Vulvar Cancer, Primary Fallopian Tube Carcinoma, Serum CA125, Biomarkers For Early Detection, Sex Cord Stromal Tumors, CAIX, Early Markers In Gynecologic Cancers, PTEN Mutation, Endometrioid Carcinoma, HE4 Level, Carbonic Anhydrase IX, lymph node metastasis, gynecologic cancers, Cyclin D1, Fallopian Tube Carcinoma, Diagnostic And Prognostic Markers Of Cancer, Early Biomarkers In Breast Cancer